These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6514933

  • 1. Similar effect of estradiol and haloperidol on experimental tardive dyskinesia in monkeys.
    Bédard PJ, Boucher R, Daigle M, Di Paolo T.
    Psychoneuroendocrinology; 1984; 9(4):375-9. PubMed ID: 6514933
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Estrogen in experimental tardive dyskinesia.
    Gordon JH, Borison RL, Diamond BI.
    Neurology; 1980 May; 30(5):551-4. PubMed ID: 7189262
    [Abstract] [Full Text] [Related]

  • 4. Antagonism of dopamine supersensitivity by estrogen: neurochemical studies in an animal model of tardive dyskinesia.
    Gordon JH, Diamond BI.
    Biol Psychiatry; 1981 Apr; 16(4):365-71. PubMed ID: 7194695
    [Abstract] [Full Text] [Related]

  • 5. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia.
    Koller W, Curtin J, Fields J.
    Neuropharmacology; 1984 Oct; 23(10):1191-4. PubMed ID: 6240609
    [Abstract] [Full Text] [Related]

  • 6. Oral tardive dyskinesia in the rat.
    Sundén-Kuronen B, Pohto P, Alanen E.
    Acta Odontol Scand; 1983 Dec; 41(6):343-8. PubMed ID: 6581673
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Modulation of dopamine receptor sensitivity by estrogen.
    Gordon JH, Borison RL, Diamond BI.
    Biol Psychiatry; 1980 Jun; 15(3):389-96. PubMed ID: 7189674
    [Abstract] [Full Text] [Related]

  • 10. Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics.
    Fields JZ, Gordon JH.
    Life Sci; 1982 Jan 18; 30(3):229-34. PubMed ID: 7200183
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ECT and tardive dyskinesia.
    Lerer B.
    J Clin Psychiatry; 1984 Apr 18; 45(4):188. PubMed ID: 6715296
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM, Matvienko OA, Nurk AM.
    Biull Eksp Biol Med; 1984 Oct 18; 98(10):444-6. PubMed ID: 6541951
    [Abstract] [Full Text] [Related]

  • 14. MK-771 antagonizes the enhanced response to apomorphine in rats treated chronically with haloperidol - implications for tardive dyskinesia.
    Yarbrough GG, Faison EP, Antolik EK.
    Neurosci Lett; 1982 Dec 31; 34(3):321-3. PubMed ID: 6819493
    [Abstract] [Full Text] [Related]

  • 15. Midification of tardive dyskinesia and spasmodic torticollis by apomorphine. Possible role of dopamine autoreceptors.
    Tolosa ES.
    Arch Neurol; 1978 Jul 31; 35(7):459-62. PubMed ID: 666598
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Behavioral and biochemical effect of chronic treatment with D-1 and/or D-2 dopamine agonists in MPTP monkeys.
    Falardeau P, Bouchard S, Bédard PJ, Boucher R, Di Paolo T.
    Eur J Pharmacol; 1988 May 20; 150(1-2):59-66. PubMed ID: 3261249
    [Abstract] [Full Text] [Related]

  • 20. Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol.
    Lublin H, Gerlach J.
    Eur J Pharmacol; 1988 Aug 24; 153(2-3):239-45. PubMed ID: 3263277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.